Change in the prevalence of extended-spectrum-β-lactamase-producing Escherichia coli in Japan by clonal spread

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 1, 2009, Pages 72-79

  Suzuki, Satowa ^a   Shibata, Naohiro ^a   Yamane, Kunikazu ^a   Wachino, Jun Ichi ^a   Ito, Kenitiro ^a   Arakawa, Yoshichika ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

CTX M; E. coli; ESBLs

Indexed keywords

AMIKACIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MINOCYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; JAPAN; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PLASMID; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; SEROTYPING; SINGLE NUCLEOTIDE POLYMORPHISM;

BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CLUSTER ANALYSIS; DNA FINGERPRINTING; EPIDEMIOLOGY, MOLECULAR; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENES, BACTERIAL; GENOTYPE; HUMANS; JAPAN; MICROBIAL SENSITIVITY TESTS; PLASMIDS; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS, DNA; SEROTYPING;

EID: 57649199656     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn463     Document Type: Article

References (31)

1. Philippon A, Labia R, Jacoby G. Extended-spectrum β-lactamases. Antimicrob Agents Chemother 1989; 33: 1131-6.
2. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: A clinical update. Clin Microbiol Rev 2005; 18: 657-86.
3. Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: An emerging public-health concern. Lancet Infect Dis 2008; 8: 159-66.
4. Jacoby G, Bush K. Amino Acid Sequences for TEM, SHV and OXA Extended-Spectrum and Inhibitor Resistant β-Lactamases. http://www.lahey.org/Studies/ (7 October 2008, date last accessed).
5. Bonnet R. Growing group of extended-spectrum β-lactamases: The CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1-14.
6. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61: 273-81.
7. Matsumoto Y, Ikeda F, Kamimura T et al. Novel plasmid-mediated β-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins. Antimicrob Agents Chemother 1988; 32 1243-6.
8. Ishi Y, Ohno A, Taguchi H et al. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A β-lactamase isolated from Escherichia coli. Antimicrob Agents Chemother 1995; 39: 2269-75.
9. Yagi T, Kurokawa H, Shibata N et al. A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol Lett 2000; 184: 53-6.
10. Shibata N, Kurokawa H, Doi Y et al. PCR classification of CTX-M-type β-lactamase genes identified in clinically isolated Gram-negative bacilli in Japan. Antimicrob Agents Chemother 2006; 50: 791-5.
11. Ministry of Health Labour and Welfare. The Japan Nosocomial Infections Surveillance. http://www.nih-janis.jp/ (7 October 2008, date last accessed).
12. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Fourteenth Informational Supplement M100-S14. NCCLS, Wayne, PA, USA, 2004.
13. Max-Planck Institut für Infektionsbiologie. MLST Databases at the MPI für Infektionsbiologie. http://web.mpiib-berlin.mpg.de/ (7 October 2008, date last accessed).
14. Tartof SY, Solberg OD, Riley LW. Genotypic analyses of uropathogenic Escherichia coli based on fimH single nucleotide polymorphisms (SNPs). J Med Microbiol 2007; 56: 1363-9.
15. Bender JB, Hedberg CW, Besser JM et al. Surveillance by molecular subtype for Escherichia coli O157:H7 infections in Minnesota by molecular subtyping. N Engl J Med 1997; 337: 388-94.
16. Yagi T, Kurokawa H, Senda K et al. Nosocomial spread of cephem-resistant Escherichia coli strains carrying multiple Toho-1-like β-lactamase genes. Antimicrob Agents Chemother 1997; 41: 2606-11.
17. Carattoli A, Bertini A, Villa L et al. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005; 63: 219-28.
18. Sabate M, Tarrago R, Navarro F et al. Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing β-lactamase (CTX-M-9) from Escherichia coli in Spain. Antimicrob Agents Chemother 2000; 44: 1970-3.
19. Chanawong A, M'Zali FH, Heritage J et al. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother 2002; 46: 630-7.
20. Bauernfeind A, Stemplinger I, Jungwirth R et al. Sequences of β-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other betalactamases. Antimicrob Agents Chemother 1996; 40: 509-13.
21. Coque TM, Novais A, Carattoli A et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis 2008; 14: 195-200.
22. BML, Inc. BML Microbiological Tests Information. http://61.114.178.39/ bct_info/index.html (7 October 2008, date last accessed).
23. Livermore DM, Canton R, Gniadkowski M et al. CTX-M: Changing the face of ESBLs in Europe. J Antimicrob Chemother 2007; 59: 165-74.
24. O'Neill PM, Talboys CA, Roberts AP et al. The rise and fall of Escherichia coli O15 in a London teaching hospital. J Med Microbiol 1990; 33: 23-7.
25. Olesen B, Kolmos HJ, Orskov F et al. A comparative study of nosocomial and community-acquired strains of Escherichia coli causing bacteraemia in a Danish University Hospital. J Hosp Infect 1995; 31: 295-304.
26. Manges AR, Johnson JR, Foxman B et al. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 2001; 345: 1007-13.
27. Ramchandani M, Manges AR, DebRoy C et al. Possible animal origin of human-associated, multidrug-resistant, uropathogenic Escherichia coli. Clin Infect Dis 2005; 40: 251-7.
28. Kojima A, Ishii Y, Ishihara K et al. Extended-spectrum-β-lactamase-producing Escherichia coli strains isolated from farm animals from 1999 to 2002: Report from the Japanese Veterinary Antimicrobial Resistance Monitoring Program. Antimicrob Agents Chemother 2005; 49: 3533-7.
29. Smet A, Martel A, Persoons D et al. Diversity of extended-spectrum β-lactamases and class C β-lactamases among cloacal Escherichia coli isolates in Belgian broiler farms. Antimicrob Agents Chemother 2008; 52: 1238-43.
30. Warren RE, Ensor VM, O'Neill P et al. Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum β-lactamases in the UK. J Antimicrob Chemother 2008; 61: 504-8.
31. Shiraki Y, Shibata N, Doi Y et al. Escherichia coli producing CTX-M-2 β-lactamase in cattle, Japan. Emerg Infect Dis 2004; 10: 69-75.